首页> 外文期刊>Quarterly Journal of Medicine >Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia
【24h】

Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia

机译:原发性混合性冰球蛋白血症患者的丙型肝炎病毒基因型

获取原文
获取原文并翻译 | 示例
       

摘要

We studied 54 patients with essential mixed cryoglobulinaemia (EMC), (23 males, 31 females) mean age 61 years (range 28-77). Forty-one (76%) had type II cryoglobulinaemia and 13 (24%) type III. Antibodies to HCV were detectable by second-generation ELISA in 49 patients (91 %) with confirmed or indeterminate RIBA results. HCV RNA was detected by RT PCR using 5′ UTR nested primers; HCV genotypes 1a, 1b, 2 and 3a were identified by genotype-specific core-region nested primers. All patients (49) with antibodies to HCV in their serum were HCV-RNA positive; 27 (55.1%) had HCV subtype 1b and 21 (42.8%) type 2. In one patient the HCV genotype could not be determined. The genotype distribution was not different from that found in patients with chronic hepatitis C without cryoglobulinaemia. However, the presence of HCV subtype 1b correlated significantly with signs of chronic hepatitis and presence of peripheral neuropathy. Severity of disease tended to be worse in patients infected with HCV subtype 1b, but this was mainly due to liver disease. HCV genotypes may influence the clinical expression and, in particular, the severity of liver involvement in patients with EMC. Extent and severity of EMC disease in general may also be affected by the different HCV genotypes. These findings may have therapeutical implications, since the different HCV genotypes respond differently to interferon treatment.
机译:我们研究了54例原发性混合性冷球蛋白血症(EMC)患者(男23例,女31例),平均年龄61岁(范围28-77)。 41名(76%)患有II型冰球蛋白血症,而13名(24%)患有III型冰球蛋白血症。 HCV抗体可通过第二代ELISA在49例确诊或不确定RIBA结果的患者中检出(91%)。使用5'UTR嵌套引物通过RT PCR检测HCV RNA。 HCV基因型1a,1b,2和3a通过基因型特异性核心区域嵌套引物鉴定。所有患者(49名)血清中抗HCV抗体均为HCV-RNA阳性。 HCV 1b型为27(55.1%),2型为21(42.8%)。在一名患者中,无法确定HCV基因型。基因型分布与无冰球蛋白血症的慢性丙型肝炎患者无差异。但是,HCV 1b亚型的存在与慢性肝炎的体征和周围神经病变的存在显着相关。在感染了HCV 1b亚型的患者中,疾病的严重程度趋于恶化,但这主要是由于肝脏疾病。 HCV基因型可能会影响EMC患者的临床表达,尤其是肝脏受累的严重程度。通常,EMC疾病的程度和严重性也可能受到不同HCV基因型的影响。这些发现可能具有治疗意义,因为不同的HCV基因型对干扰素治疗的反应不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号